Seeing Is Believing

Currently out of the existing stock ratings of James Terwilliger, 15 are a BUY (71.43%), 6 are a HOLD (28.57%).
Analyst James Terwilliger, carries an average stock price target met ratio of 48.33% that have a potential upside of 32.87% achieved within 326 days.
James Terwilliger’s has documented 41 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on INFU, InfuSystems Holdings at 29-Dec-2021.
Analyst best performing recommendations are on ZYXI (ZYNEX).
The best stock recommendation documented was for ZYXI (ZYNEX) at 4/1/2020. The price target of $13.64 was fulfilled within 29 days with a profit of $4.72 (52.91%) receiving and performance score of 18.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$25
$5 (25.00%)
$48
2 years 10 months 19 days ago
(14-Dec-2022)
4/8 (50%)
$10.95 (77.94%)
512
Hold
$18
$-2 (-10.00%)
$32
3 years 4 months 24 days ago
(08-Jun-2022)
3/4 (75%)
$2.82 (18.58%)
194
Buy
$20
$20
3 years 5 months 28 days ago
(05-May-2022)
12/13 (92.31%)
$4.32 (27.55%)
430
Buy
$34
$14 (70.00%)
$40
3 years 8 months 30 days ago
(03-Feb-2022)
1/4 (25%)
$17.86 (110.66%)
295
Hold
$49
3 years 11 months 15 days ago
(18-Nov-2021)
9/11 (81.82%)
$15.13 (44.67%)
234
What Year was the first public recommendation made by James Terwilliger?